Colgate-Palmolive Company CL reported an earnings beat for the first time in four quarters in late April, and investors should consider buying the stock, according to Argus.
The Analyst
Argus' John Eade upgraded Colgate-Palmolive's stock from Hold to Buy with a new $72 price target.
The Thesis
Colgate's stock has fallen around 10 percent over the past three months and 16 percent over the past year, Eade said in the upgrade note. (See the analyst's track record here.)
The stock's underperformance versus the broader market — coupled with the first earnings beat in one year — implies that Colgate now offers "value" to investors near its 52-week low levels, the analyst said. The chart is showing a "bearish pattern of lower highs and lower lows" that dates back to the start of 2018, but should now move higher, he said.
Colgate's strong focus on emerging markets and segments like mouthwash, toothpaste and toothbrushes should help the company grow its earnings and cash flow better than its peers, Eade said. The company also boasts an "exemplary record" of dividend growth, having raised its payout to investors for more than 50 years. Colgate is projected to lift its dividend payout from $1.63 per share to $1.71 per share in 2019.
Price Action
Colgate-Palmolive shares were trading higher by 1.87 percent at the time of publication Friday.
Bernstein: Colgate's Got A Target On Its Back For Activist Investors
Morgan Stanley Shifts To Neutral On Colgate-Palmolive, Cites Emerging Markets Weakness
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.